Series B - BridgeBio Pharma - May 1, 2017 Funding Round Profile - Cointime

Bitcoin $98,677.87 +0.57%
Ethereum $3,334.96 +5.92%
BNB $622.91 +2.29%
Optimism $2.09 +24.77%
Arbitrum $0.78 +12.19%
Solana $257.41 +6.51%
Polygon $0.46 +5.35%
Cosmos $6.74 +10.64%
Avalanche $36.99 +9.60%

Bitcoin $98,677.87 +0.57%
Ethereum $3,334.96 +5.92%
BNB $622.91 +2.29%
Optimism $2.09 +24.77%
Arbitrum $0.78 +12.19%
Solana $257.41 +6.51%
Polygon $0.46 +5.35%
Cosmos $6.74 +10.64%
Avalanche $36.99 +9.60%

BridgeBio Pharma

company

Funding Round

Series B

Money Raised

$ 33.10M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Kohlberg Kravis Roberts	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Mar 1, 2016	Series B	$ 6.90M	Kohlberg Kravis Roberts	Detail